Xiaobing Cui
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Gastroenterology top 5%
Papers in
-
- Gut microbiota and health 2
- RNA Research and Splicing 2
-
- Cancer-related molecular mechanisms research 4
- Co-authors
- Jing Li (2 shared papers)Ling Jin (3 shared papers)Minghui Bao (2 shared papers)Bin Geng (3 shared papers)Shuangyue Li (3 shared papers)Jun Cai (3 shared papers)Wenjie Wang (2 shared papers)Lifeng Li (1 shared paper)
- Journals
- Medicine (2 papers)Scientific Reports (2 papers)Inflammation Research (1 paper)Drug Resistance Updates (1 paper)Frontiers in Microbiology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaobing Cui
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 239
- Gastroenterology 70
- Biological Psychiatry 17
- Molecular Biology 494
- Physiology 142
Countries citing papers authored by Xiaobing Cui
This map shows the geographic impact of Xiaobing Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Cui more than expected).
Fields of papers citing papers by Xiaobing Cui
This network shows the impact of papers produced by Xiaobing Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Cui. The network helps show where Xiaobing Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobing Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 282 | |
| 2 | 2017 | 84 | |
| 3 | 2014 | 63 | |
| 4 | 2012 | 61 | |
| 5 | 2012 | 60 | |
| 6 | 2015 | 54 | |
| 7 | 2013 | 40 | |
| 8 | 2014 | 40 | |
| 9 | 2019 | 37 | |
| 10 | 2014 | 34 | |
| 11 | 2019 | 29 | |
| 12 | 2018 | 29 | |
| 13 | 2014 | 27 | |
| 14 | 2015 | 26 | |
| 15 | 2019 | 24 | |
| 16 | Trichosanatine alleviates oxidized low-density lipoprotein induced endothelial cells injury via inhibiting the LOX-1/p38 MAPK pathway. | 2016 | 20 |
| 17 | 2016 | 17 | |
| 18 | 2022 | 15 | |
| 19 | 2013 | 13 | |
| 20 | 2018 | 10 |
About Xiaobing Cui
Xiaobing Cui is a scholar working on Molecular Biology, Cancer Research, Immunology, Infectious Diseases and Surgery, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Tuberculosis Research and Epidemiology (4 papers), Phytochemistry and Biological Activities (2 papers), Gut microbiota and health (2 papers), RNA Research and Splicing (2 papers), Mycobacterium research and diagnosis (2 papers), Berberine and alkaloids research (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Cancer Research (239 citations), Gastroenterology (70 citations), Biological Psychiatry (17 citations), Molecular Biology (494 citations) and Physiology (142 citations). Xiaobing Cui has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jing Li, Ling Jin, Minghui Bao, Bin Geng, Shuangyue Li, Jun Cai, Wenjie Wang, Lifeng Li, Shouling Wu and Jian Zhang. Their work appears in journals such as Medicine, Scientific Reports, Inflammation Research, Drug Resistance Updates and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.